Ronocit solution for injection 500 mg/4 ml, 5 ampoules — Made in Romania — Free Delivery

Stroke, acute phase of cerebrovascular accidents and treatment of complications and consequences of cerebrovascular accidents; traumatic brain injury and its neurological complications; cognitive and behavioral disorders due to chronic vascular and degenerative brain disorders.

The preparation is used for intravenous or intramuscular administration, i.v. is prescribed in the form of a slow i.v. injection (within 3–5 minutes, depending on the prescribed dose) or intravenous drip (40–60 drops per minute).

The recommended dose for adults is 500–2000 mg/day, depending on the severity of the patient's condition.

The maximum daily dose is 2000 mg.

In acute and urgent conditions, the maximum therapeutic effect is achieved when the preparation is administered in the first 24 hours.

The duration of treatment depends on the course of the disease and is determined by the doctor.

For elderly patients, dose adjustment is not required.

The preparation is compatible with all intravenous isotonic solutions, as well as with hypertonic glucose solutions.

This solution is intended for single use. The solution must be administered immediately after opening the ampoule. Unused solution should be destroyed.

If necessary, treatment continues to use citicoline in the form of a solution for oral administration.

Children. There are no sufficient data on the use of the preparation in children.

Hypersensitivity to any component of the preparation. increased tone of the parasympathetic nervous system.

Very rare (1/10,000) (including patient reports).

From the side of the central and peripheral nervous system: severe headache, vertigo, hallucinations.

From the side of the cardiovascular system: hypertension, arterial hypotension, tachycardia.

From the respiratory system: shortness of breath.

From the digestive system: nausea, vomiting, diarrhea.

From the skin: hyperemia, allergic rash, rash, purpura, urticaria, itching, angioedema, anaphylactic shock.

General reactions: chills, edema, changes at the injection site.

In case of persistent intracranial bleeding, the preparation is recommended to be administered as a very slow IV infusion (30 drops per minute) and not to exceed a daily dose of 1000 mg.

Use during pregnancy or lactation. Sufficient data on the use of citicoline in pregnant women are not available. It is possible to use the preparation during pregnancy and lactation only when the expected benefit to the mother outweighs the possible risk to the fetus or child.

Data on the penetration of citicoline into breast milk are not available.

The ability to influence the reaction rate when driving vehicles or other mechanisms. Citicoline does not affect the ability to drive vehicles and work with complex mechanisms.

Do not use the preparation simultaneously with preparations containing meclofenoxate. enhances the effect of levodopa.

Incompatibility. Do not use solvents not listed in the APPLICATION section.

Unknown. given the low toxicity of the preparation, the likelihood of poisoning is low, even if therapeutic doses are accidentally exceeded.

At a temperature not higher than 25 ° C.